Company / Operating Margin
LENZ Therapeutics, Inc. Operating Margin History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-477.5%
FY2025
5-year range
-477.5% / -477.5%
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#110 of 136
Health Care
What the data says
LENZ Therapeutics, Inc.'s operating margin of -477.5% is lower than 81% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
-477.5% in FY2025.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 136This company -477.5% Sector average -778.9%
▼
+38.7% above sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -477.5% | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026